Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Common Equity (2016 - 2025)

Harte Hanks has reported Common Equity over the past 16 years, most recently at $20.5 million for Q4 2025.

  • Quarterly Common Equity fell 5.36% to $20.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.5 million through Dec 2025, down 5.36% year-over-year, with the annual reading at $20.5 million for FY2025, 5.36% down from the prior year.
  • Common Equity was $20.5 million for Q4 2025 at Harte Hanks, up from $19.9 million in the prior quarter.
  • Over five years, Common Equity peaked at $22.2 million in Q2 2025 and troughed at -$54.4 million in Q1 2021.
  • The 5-year median for Common Equity is $19.9 million (2024), against an average of $2.8 million.
  • Year-over-year, Common Equity fell 22.88% in 2021 and then surged 260.33% in 2023.
  • A 5-year view of Common Equity shows it stood at -$24.7 million in 2021, then skyrocketed by 176.1% to $18.8 million in 2022, then increased by 5.58% to $19.9 million in 2023, then grew by 9.23% to $21.7 million in 2024, then decreased by 5.36% to $20.5 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Common Equity are $20.5 million (Q4 2025), $19.9 million (Q3 2025), and $22.2 million (Q2 2025).